Viridian Therapeutics, Inc.\DE (VRDN) Interest Coverage Ratio (QoQ) (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) Interest Coverage Ratio (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.28% |
| Dec 31, 2025 | 47.66% |
| Sep 30, 2025 | -216.08% |
| Jun 30, 2025 | 86.75% |
| Mar 31, 2025 | 72.68% |
| Dec 31, 2024 | -11,518.83% |
| Sep 30, 2024 | 95.55% |
| Jun 30, 2024 | -135.36% |
| Mar 31, 2024 | 71.25% |
| Dec 31, 2023 | -109.31% |
| Sep 30, 2023 | 76.09% |
| Jun 30, 2023 | 1.46% |
| Mar 31, 2023 | -118.46% |
| Dec 31, 2022 | 1,417.87% |
| Sep 30, 2022 | -0.75% |
| Mar 31, 2021 | 94.79% |
| Dec 31, 2020 | -8,109.02% |
| Sep 30, 2020 | -1.85% |
| Jun 30, 2020 | 7.02% |
| Sep 30, 2019 | -6.97% |